These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Hara K; Akiyama Y; Nakamura T; Murota S; Morita I Bone; 1995 Feb; 16(2):179-84. PubMed ID: 7756045 [TBL] [Abstract][Full Text] [Related]
4. Effects of mexiletine on algogenic mediator-induced nociceptive responses in mice. Hitosugi H; Kashiwazaki T; Ohsawa M; Kamei J Methods Find Exp Clin Pharmacol; 1999; 21(6):409-13. PubMed ID: 10445233 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Koshihara Y; Hoshi K; Shiraki M Biochem Pharmacol; 1993 Oct; 46(8):1355-62. PubMed ID: 8240383 [TBL] [Abstract][Full Text] [Related]
6. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. Hara K; Akiyama Y; Tajima T; Shiraki M J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981 [TBL] [Abstract][Full Text] [Related]
7. Antinociceptive profiles and mechanisms of centrally administered oxyntomodulin in various mouse pain models. Park SH; Lee JR; Jang SP; Park SH; Lee HJ; Hong JW; Suh HW Neuropeptides; 2018 Apr; 68():7-14. PubMed ID: 29366515 [TBL] [Abstract][Full Text] [Related]
8. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice. Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315 [TBL] [Abstract][Full Text] [Related]
9. Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test. Mjellem-Joly N; Lund A; Berge OG; Hole K Pain; 1992 Nov; 51(2):195-198. PubMed ID: 1283010 [TBL] [Abstract][Full Text] [Related]
10. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Choi SS; Lee JK; Suh HW Brain Res; 2001 Dec; 921(1-2):233-9. PubMed ID: 11720731 [TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Akiyama Y; Hara K; Tajima T; Murota S; Morita I Eur J Pharmacol; 1994 Sep; 263(1-2):181-5. PubMed ID: 7821350 [TBL] [Abstract][Full Text] [Related]
13. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
14. Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDA. Masuyama T; Shimizu T Brain Res; 1997 Jun; 759(2):241-6. PubMed ID: 9221943 [TBL] [Abstract][Full Text] [Related]
15. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Akiyama Y; Hara K; Ohkawa I; Tajima T Jpn J Pharmacol; 1993 Jun; 62(2):145-53. PubMed ID: 8371513 [TBL] [Abstract][Full Text] [Related]